DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Oncology Homepage

IBM and Elekta collab to bridge global cancer care gaps Combining Elekta’s MOSAIQ and IBM’s Watson for Oncology

Vladimir Putin meets with health leaders Discussing the role of proton therapy in Russian health care

New PET imaging agent predicts tumor response to lung cancer drug Could lead to better patient management and outcomes

Study finds most breast cancer patients have better experience with radiation than expected May help put fears to rest

How Mayo Clinic and IBM Watson dramatically improved clinical trial enrollment Mayo sees 80 percent rise in breast cancer trial enrollees

Is proton therapy out of reach for pediatric patients? Initiatives and challenges on the road to improving access to life saving treatment

RaySearch and MD Anderson team up to enhance radiotherapy Aim to raise access to adaptive radiation therapy

Elekta partners with Memorial Sloan Kettering for cancer research on MR-linac Will test MR-linac in treating tumors in nine parts of the body

Pam Papineau Imagin Medical hires director of regulatory affairs

Varian acquires Evinance Enhances adherence tracking based on NCCN guidelines

Proton therapy treatments, technology and access grow exponentially

by John W. Mitchell , Senior Correspondent
On the occasion of the facility's 10 year anniversary, a professor at the University of Florida Health Proton Therapy Institute (UFHPTI) looked back on the evolution of proton therapy as an advanced weapon against cancer.

When UFHPTI opened, it was the first proton treatment center in the southeastern U.S. Since then, the number of centers in the U.S. has increased from five to over 20 locations today.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.

“In 2006, proton therapy was limited mostly to just prostate cancer, pediatric brain tumors, melanomas of the eye, and rare tumors of the base of skull and paranasal sinuses,” Dr. Bradford Hoppe, MPH, the James E. Lockwood, Jr. Professor in Proton Therapy at UFHPTI, told HCB News. “In the last 10 years, there has been exploration and interest in utilizing proton therapy for head and neck cancer, lung cancer, breast cancer, cancer of the GI tract, sarcomas, pediatric non-CNS cancers, and lymphoma.”

Since 2006, UFHPTI has treated more than 20 different types of cancers in more than 6,400 patients, and has published over 130 peer-reviewed journal articles on proton therapy.

Over that time, Hoppe said, technological advancements have coincided with the increase in the number of proton facilities. “Pencil beam scanning and in-room imaging for patients allows us to provide better treatment planning with proton therapy for a number of different sites,” He said.

“Additionally, smaller, more compact and cost-efficient equipment allows more centers the ability to offer proton therapy treatment.”

Fortunately, many of the older models of proton cyclotrons can be upgraded. Hoppe said the UFHPTI center will be upgraded with pencil beam scanning and a single compact room, all part of a $39 million expansion at the center to increase patient capacity by 25 percent, including treating more kids. According to Hoppe, they operate the busiest pediatric proton treatment center in the world and the fourth busiest program overall.

“Pediatric patients are a group that we recognized could benefit the most from proton therapy in reducing both acute and late side effects,” Hoppe explained.

He said to better treat children, they have developed a multidisciplinary team of child life specialists and social workers, as well as establishing relationships with physicians from a large academic medical center.

According to a 2012 Journal of the National Cancer Institute study, the median Medicare reimbursement for proton therapy for prostate cancer is $32,428 compared to $18,575 for traditional intensity-modulated radiation therapy (IMRT).

However, proton advocates maintain that the overall costs compared to IMRT are less, because proton patients experience fewer side effects. This, they assert, results in a better quality of life, which reduces ongoing medical and societal costs. Proton therapy has also been shown to offer significantly improved outcomes for treating head and neck tumors.

Oncology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.